Pin your most used calculators here by clicking the star in the dropdown.
Mesothelioma EORTC Prognostic Index
Clinical Context & Background
The EORTC Prognostic Index identifies poor prognostic factors for patients with Malignant Pleural Mesothelioma. It stratifies patients into low or high risk groups, which helps guide treatment decisions (e.g., aggressive multimodal therapy vs. supportive care).
Formula Logic
Score based on WBC, Performance Status, Histology, Gender, and Diagnosis Certainty.Reference Data
| Risk Group | Score | Median Survival (Historical) |
|---|---|---|
| Low Risk | 0 - 1.27 | 10.8 months |
| High Risk | > 1.27 | 5.5 months |
Related Tools
Evidence-based oncology decision support. Verify with clinical guidelines.